Climate adapted inhalation therapy for COPD
The goal of this research project is to examine if certain drugs have an influence whether a chronic obstructive pulmonary disease worsens during a heat wave or not.
You are here:
Climate adapted inhalation therapy for COPD – adaptation strategy for the prevention of a heat stress associated exacerbation - a prospective study in the metropolitan area of Berlin
DRKS-ID of the study: DRKS00013370
Through the impacts of global climate change the residents of Germany experince more heat waves. These are a burden for patients with a chronic lung disease. The goal of this prospective study is to find out whether certain drugs further an exacerbation of a chronic lung disease (COPD) during a heat wave.
Therefore, COPD patients who are stationary treated due to an acute exacerbation of their disease are questioned which medication they take and in what frequency. Depending on the outdoor temperature, these patients are either assigned to the "heat stress goup" (mean daily temperature > 21°C) or the control group (mean daily temperature between 10 and 21°C).
If this study is successful in identifying drugs which, in relation to high temperatures, influence the condition of COPD patients, it gives us the opportunity to devise a climate adapted medical therapy.
This study is funded by AstraZeneca GmbH.